nDatalyze announces a Letter of Intent with the Canadian Mental Health Association, Dr. Andrew Greenshaw, and Dr. Bo Cao – December 18, 2023



nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces a Letter of Intent with the Canadian Mental Health Association, Dr. Andrew Greenshaw, and Dr. Bo Cao.


Calgary, Alberta – December 18, 2023

For Immediate Release – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces that on December 15, 2023, the Corporation signed a Letter of Intent (“LOI”) with the Canadian Mental Health Association, Edmonton Region (“CMHA_E”), Dr. Andrew Greenshaw, and Dr. Bo Cao (collectively the “Parties”) whereby the Parties have agreed to organize and conduct the Psychiatric aspect (“Project”) of the Corporation’s previously-announced Clinical Study. A formal agreement setting out protocols and specifics is expected within 60 days. The Project will be overseen by Giri Puligandla, CMHA_E Executive Director, and the Principal Investigators will be Dr. Bo Cao, assistant professor in Computational Psychiatry at the Department of Psychiatry, University of Alberta and Canada Research Chair (CRC; Tier 2), and Dr. Andrew Greenshaw, Professor of Psychiatry and Neuroscience at the University of Alberta. Dr. Greenshaw is Chairman of the Board of Directors at Mental Health Research Canada and has also served on numerous Canadian Medical Research Council and Canadian Institutes of Health Research (CIHR) grant panels. Dr. Greenshaw maintains extensive high-level relationships within the mental health system.

James Durward, CEO/CTO states: “Since our YMI system was conceived, we have been working to bring together the elements believed necessary to significantly improve population-wide mental health. This is a major undertaking that involves not only complex technical issues, but also the relationships necessary to deploy advanced systems throughout the mental health system. I believe that by combining our unique Reference Database and machine-learning processes with some of the brightest minds in the field, the stage is now set to have our YMI system not only validated, but also positioned for deployment.”

The Corporation will finance the Clinical Study with existing cash reserves.



YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops and to improve mental wellbeing. YMI combines machine-learning with a proprietary Reference Database that contains >1200 person’s genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle to generate a personalized graphic report predicting an individual’s predisposition toward a variety of common mental conditions, both current and forward in time.



Dr. Keith Courtney, President (psychiatric aspects)
Email: [email protected]

James Durward, CEO&CTO (technical aspects)
Telephone: (403) 689-3901
Email: [email protected]

Website: www.ndatalyze.com

YMI Website: https://ymihealth.ca


Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.